Paean Biotechnology
Latest round
- Series A
Last raised
- Jul 2019
Total raised
- $5.1M
Investors
- 3
About Paean Biotechnology
Founded in 2013 in Daejeon, South Korea, Paean Biotechnology specializes in mitochondrial therapies. The founder's background is not publicly detailed, nor does the company have known subsidiaries. Paean Biotechnology specializes in mitochondria-based therapeutics, positioning itself as a leader in the development of biopharmaceutical agents that utilize modified mitochondria to address rare diseases and cancer. Their core product offerings include MitoTherapy and Mitoceuticals. MitoTherapy products are designed to enhance cellular function and energy production through the application of allogenic mitochondria, while Mitoceuticals focus on modified formulations that aim to improve overall mitochondrial health. These products primarily serve healthcare providers and research institutions in various international markets, including South Korea and regions in Europe, where they are positioned to support clinical applications and research initiatives. The company’s innovative use of proprietary technology for isolating, storing, and modifying mitochondria marks a significant advancement in therapeutic options for patients suffering from debilitating conditions. The company engages in B2B transactions with healthcare providers and research institutions, facilitating access to their flagship products, MitoTherapy and Mitoceuticals. Specific pricing plans for products and services are tailored to the needs of clinical partners and may involve negotiated rates for bulk access or exclusive rights to product offerings. Overall, the structured transaction model leverages collaborations that enhance the reach and application of Paean Biotechnology's innovative mitochondrial therapies. Paean Biotechnology is actively pursuing the development of new mitochondrial-based therapeutic products, with a focus on launching these innovations in the upcoming years. The company aims to expand its market presence primarily in Europe and North America by 2023.
Who invested in Paean Biotechnology
3 investors across 1 round
See all investors in Paean Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 8, 2019
Amount
$5.1M
Investors
Questions about Paean Biotechnology
Who invested in Paean Biotechnology?
Paean Biotechnology has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Paean Biotechnology raised?
Paean Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Paean Biotechnology last raise money?
Paean Biotechnology's most recent round on record is a Series A, in Jul 2019.
What does Paean Biotechnology do?
Founded in 2013 in Daejeon, South Korea, Paean Biotechnology specializes in mitochondrial therapies.
Where is Paean Biotechnology headquartered?
Paean Biotechnology is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Paean Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Paean Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Paean Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.